Daiwa Securities Group Inc. Has $4.03 Million Stock Position in Humana Inc. (NYSE:HUM)

Daiwa Securities Group Inc. boosted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 7.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,875 shares of the insurance provider's stock after purchasing an additional 1,113 shares during the quarter. Daiwa Securities Group Inc.'s holdings in Humana were worth $4,028,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. State Street Corp lifted its position in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock valued at $1,701,582,000 after purchasing an additional 53,272 shares during the period. FMR LLC lifted its position in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Pzena Investment Management LLC lifted its position in Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock valued at $793,830,000 after purchasing an additional 187,903 shares during the period. Ontario Teachers Pension Plan Board lifted its position in Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after purchasing an additional 71,910 shares during the period. Finally, Sanders Capital LLC raised its position in shares of Humana by 1.0% in the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider's stock valued at $370,060,000 after acquiring an additional 11,923 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.32% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of analyst reports. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Truist Financial increased their price target on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Barclays increased their price target on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. lowered their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, Humana has a consensus rating of "Hold" and an average price target of $285.68.

Humana Stock Up 0.5 %

Shares of HUM traded up $1.38 during mid-day trading on Friday, hitting $253.11. 1,331,284 shares of the company's stock were exchanged, compared to its average volume of 1,716,373. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company has a 50-day simple moving average of $271.37 and a 200 day simple moving average of $280.01. The company has a market cap of $30.55 billion, a PE ratio of 25.44, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.40%. Humana's dividend payout ratio is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.